- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0003264

Adegen Pharma Private Limited
About Adegen Pharma Private Limited
Data last updated:
Adegen Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2020PTC085571. Its GSTIN is 06AATCA3425F1ZQ (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pooja Singla and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Raipur Rani Panchkula Ambala, Haryana, India – 134204.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.37 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹76,900 (net margin 0.6%) and EBITDA of ₹5.36 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 142% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Adegen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0003264).
Company details
Recognitions & Rankings of Adegen Pharma
Contact details
Adegen Pharma Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressRaipur Rani Panchkula Ambala, Haryana, India – 134204
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adegen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adegen Pharma Private Limited, buy the company report.
Financials of Adegen Pharma Private Limited
FY 2025 filings availableAdegen Pharma Private Limited reported revenue of ₹1.37 Cr (up 23% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 142% over three years, including 23% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76,900 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adegen Pharma Private Limited, buy the company report.
Board of directors of Adegen Pharma Private Limited
Adegen Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Singla | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Sanjeev Kumar | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Ritu Singla | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Adegen Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioglaze Biotech Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Ambala Cantt, Haryana, India | |||
| Manspic Formulation Private Limited | ₹1.38 Cr (FY 2025) | -49.0% | Gwalior, Madhya Pradesh, India | |||
| Sierra Pharmaceuticals Limited. | ₹1.38 Cr (FY 2024) | -11.0% | New Delhi, Delhi, India | |||
| Dekster Life Sciences Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Thrissur, Kerala, India | |||
| Ranvin Healthcare Private Limited | ₹1.37 Cr (FY 2025) | 101.0% | Kanpur Nagar, Uttar Pradesh, India | |||
| Adegen Pharma Private Limitedthis company | ₹1.37 Cr (FY 2024) | ₹76,900 | 0.6% | 23.0% | Panchkula, Haryana, India | |
| Mencure Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 12.0% | Patna, Bihar, India | |||
| South India Drugs Export and Laboratory Private Limited | ₹1.36 Cr (FY 2025) | -10.0% | Chennai, Tamil Nadu, India | |||
| Aatmos Pharma (OPC) Private Limited | ₹1.36 Cr (FY 2025) | -2.0% | Karnal, Haryana, India | |||
| Vendan Medicals Private Limited | ₹1.36 Cr (FY 2023) | -58.0% | Annalagraharam, Tamil Nadu, India |
To see the full peer comparison of Adegen Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 May 2024 | 100920392 | Hdfc Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Adegen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adegen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adegen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCA3425F1ZQ | Haryana | Active | 13 May 2020 |
To see the full GST registrations and return filing status of Adegen Pharma Private Limited, buy the company report.
Recent activity
Adegen Pharma Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Lalita Devi ceased to be Director on 05 Mar 2021.
Frequently asked questions
Adegen Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 February 2020 (6+ years old) and is registered under CIN U24304HR2020PTC085571.
Adegen Pharma has 3 current directors:
- Pooja Singla - Director
- Sanjeev Kumar - Director
- Ritu Singla - Director
The latest financial statements of Adegen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Adegen Pharma is 06AATCA3425F1ZQ, registered in Haryana.
The CIN (Corporate Identification Number) of Adegen Pharma is U24304HR2020PTC085571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adegen Pharma was incorporated on 24 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Adegen Pharma by revenue are Bioglaze Biotech Private Limited, Manspic Formulation Private Limited, Sierra Pharmaceuticals Limited, Dekster Life Sciences Private Limited, Ranvin Healthcare Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Lalita Devi ceased to be Director on 05 Mar 2021. Parveen Kumar ceased to be Director on 05 Mar 2021. Pooja Singla was appointed as Director on 22 Feb 2021. Adegen Pharma has 5 board changes on record in total.
Yes, Adegen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0003264).
The registered office of Adegen Pharma is at Raipur Rani Panchkula Ambala, Haryana, India – 134204.
Adegen Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.